[Federal Register Volume 80, Number 166 (Thursday, August 27, 2015)]
[Notices]
[Pages 52045-52046]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-21248]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-15-0571]


Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) has submitted 
the following information collection request to the Office of 
Management and Budget (OMB) for review and approval in accordance with 
the Paperwork Reduction Act of 1995. The notice for the proposed 
information collection is published to obtain comments from the public 
and affected agencies.
    Written comments and suggestions from the public and affected 
agencies concerning the proposed collection of information are 
encouraged. Your comments should address any of the following: (a) 
Evaluate whether the proposed collection of information is necessary 
for the proper performance of the functions of the agency, including 
whether the information will have practical utility; (b) Evaluate the 
accuracy of the agencies estimate of the burden of the proposed 
collection of information, including the validity of the methodology 
and assumptions used; (c) Enhance the quality, utility, and clarity of 
the information to be collected; (d) Minimize the burden of the 
collection of information on those who are to respond, including 
through the use of appropriate automated, electronic, mechanical, or 
other technological collection techniques or other forms of information 
technology, e.g., permitting electronic submission of responses; and 
(e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570 or send an email to [email protected]. Written comments and/or 
suggestions regarding the items contained in this notice should be 
directed to the Attention: CDC Desk Officer, Office of Management and 
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written 
comments should be received within 30 days of this notice.

Proposed Project

    Minimum Data Elements (MDEs) for the National Breast and Cervical 
Cancer Early Detection Program (NBCCEDP) (OMB No. 0920-0571, exp. 10/
31/2015)--Extension--National Center for Chronic Disease Prevention and 
Health

[[Page 52046]]

Promotion (NCCDPHP), Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    Many cancer-related deaths in women could be avoided by increased 
utilization of appropriate screening and early detection tests for 
breast and cervical cancer. Mammography is extremely valuable as an 
early detection tool because it can detect breast cancer well before 
the woman can feel the lump, when the cancer is still in an early and 
more treatable stage. Similarly, a substantial proportion of cervical 
cancer-related deaths could be prevented through the detection and 
treatment of precancerous lesions. The Papanicolaou (Pap) test is the 
primary method of detecting both precancerous cervical lesions as well 
as invasive cervical cancer. Mammography and Pap tests are underused by 
women who have no source or no regular source of health care and women 
without health insurance.
    The CDC's National Breast and Cervical Cancer Early Detection 
Program (NBCCEDP) provides screening services to underserved women 
through cooperative agreements with 50 States, the District of 
Columbia, 5 U.S. Territories, and 11 American Indian/Alaska Native 
tribal programs. The program was established in response to the Breast 
and Cervical Cancer Mortality Prevention Act of 1990. Screening 
services include clinical breast examinations, mammograms and Pap 
tests, as well as timely and adequate diagnostic testing for abnormal 
results, and referrals to treatment for cancers detected. NBCCEDP 
awardees collect patient-level screening and tracking data to manage 
the program and clinical services. A de-identified subset of data on 
patient demographics, screening tests and outcomes are reported by each 
awardee to CDC twice per year.
    CDC is requesting OMB approval to collect MDE information for an 
additional three years. There are no changes to the currently approved 
minimum data elements, electronic data collection procedures, or the 
estimated burden. Because NBCCEDP awardees already collect and 
aggregate data at the state, territory and tribal level, the additional 
burden of submitting data to CDC will be modest. CDC will use the 
information to monitor and evaluate NBCCEDP awardees; improve the 
availability and quality of screening and diagnostic services for 
underserved women; develop outreach strategies for women who are never 
or rarely screened for breast and cervical cancer, and report program 
results to Congress and other legislative authorities.
    There are no costs to respondents other than their time. The total 
estimated annualized burden hours are 536.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                   Number of      Average burden
         Type of respondents                 Form name            Number of      responses per     per response
                                                                 respondents       respondent       (in hrs.)
----------------------------------------------------------------------------------------------------------------
NBCCEDP Awardees....................  Minimum Data Elements..              67                2                4
----------------------------------------------------------------------------------------------------------------


Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2015-21248 Filed 8-26-15; 8:45 am]
 BILLING CODE 4163-18-P